Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Volonte

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
FEBS Letters|March 27, 1999
Visualization of caveolin-1, a caveolar marker protein, in living cells using green fluorescent protein (GFP) chimeras. The subcellular distribution of caveolin-1 is modulated by cell-cell contactD Volonte, F Galbiati, M P Lisanti
The Journal of Biological Chemistry|August 28, 1999
Phenotypic behavior of caveolin-3 mutations that cause autosomal dominant limb girdle muscular dystrophy (LGMD-1C). Retention of LGMD-1C caveolin-3 mutants within the golgi complexF Galbiati, D Volonte, C Minetti, et al.
The Journal of Biological Chemistry|September 7, 2000
Limb-girdle muscular dystrophy (LGMD-1C) mutants of caveolin-3 undergo ubiquitination and proteasomal degradation. Treatment with proteasomal inhibitors blocks the dominant negative effect of LGMD-1C mutanta and rescues wild-type caveolin-3F Galbiati, D Volonte, C Minetti, et al.
FEBS Letters|December 9, 1998
Upregulation of caveolin-1 and caveolae organelles in Taxol-resistant A549 cellsC P Yang, F Galbiati, D Volonte, et al.
The Journal of Biological Chemistry|April 23, 1999
Flotillins/cavatellins are differentially expressed in cells and tissues and form a hetero-oligomeric complex with caveolins in vivo. Characterization and epitope-mapping of a novel flotillin-1 monoclonal antibody probeD Volonte, F Galbiati, S Li, et al.
The Journal of Biological Chemistry|October 9, 1999
Targeted down-regulation of caveolin-3 is sufficient to inhibit myotube formation in differentiating C2C12 myoblasts. Transient activation of p38 mitogen-activated protein kinase is required for induction of caveolin-3 expression and subsequent myotube formationF Galbiati, D Volonte, J A Engelman, et al.
The Journal of Biological Chemistry|February 20, 1999
The dually acylated NH2-terminal domain of gi1alpha is sufficient to target a green fluorescent protein reporter to caveolin-enriched plasma membrane domains. Palmitoylation of caveolin-1 is required for the recognition of dually acylated g-protein alpha subunits in vivoF Galbiati, D Volonte, D Meani, et al.
The EMBO Journal|November 21, 1998
Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascadeF Galbiati, D Volonte, J A Engelman, et al.
American Journal of Physiology. Cell Physiology|April 5, 2001
Influence of caveolin-1 on cellular cholesterol efflux mediated by high-density lipoproteinsP G Frank, F Galbiati, D Volonte, et al.
FEBS Letters|September 17, 1998
Mutational analysis of caveolin-induced vesicle formation. Expression of caveolin-1 recruits caveolin-2 to caveolae membranesS Li, F Galbiati, D Volonte, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
FEBS Letters|March 27, 1999
Visualization of caveolin-1, a caveolar marker protein, in living cells using green fluorescent protein (GFP) chimeras. The subcellular distribution of caveolin-1 is modulated by cell-cell contactD Volonte, F Galbiati, M P Lisanti
The Journal of Biological Chemistry|August 28, 1999
Phenotypic behavior of caveolin-3 mutations that cause autosomal dominant limb girdle muscular dystrophy (LGMD-1C). Retention of LGMD-1C caveolin-3 mutants within the golgi complexF Galbiati, D Volonte, C Minetti, et al.
The Journal of Biological Chemistry|September 7, 2000
Limb-girdle muscular dystrophy (LGMD-1C) mutants of caveolin-3 undergo ubiquitination and proteasomal degradation. Treatment with proteasomal inhibitors blocks the dominant negative effect of LGMD-1C mutanta and rescues wild-type caveolin-3F Galbiati, D Volonte, C Minetti, et al.
FEBS Letters|December 9, 1998
Upregulation of caveolin-1 and caveolae organelles in Taxol-resistant A549 cellsC P Yang, F Galbiati, D Volonte, et al.
The Journal of Biological Chemistry|April 23, 1999
Flotillins/cavatellins are differentially expressed in cells and tissues and form a hetero-oligomeric complex with caveolins in vivo. Characterization and epitope-mapping of a novel flotillin-1 monoclonal antibody probeD Volonte, F Galbiati, S Li, et al.
The Journal of Biological Chemistry|October 9, 1999
Targeted down-regulation of caveolin-3 is sufficient to inhibit myotube formation in differentiating C2C12 myoblasts. Transient activation of p38 mitogen-activated protein kinase is required for induction of caveolin-3 expression and subsequent myotube formationF Galbiati, D Volonte, J A Engelman, et al.
The Journal of Biological Chemistry|February 20, 1999
The dually acylated NH2-terminal domain of gi1alpha is sufficient to target a green fluorescent protein reporter to caveolin-enriched plasma membrane domains. Palmitoylation of caveolin-1 is required for the recognition of dually acylated g-protein alpha subunits in vivoF Galbiati, D Volonte, D Meani, et al.
The EMBO Journal|November 21, 1998
Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascadeF Galbiati, D Volonte, J A Engelman, et al.
American Journal of Physiology. Cell Physiology|April 5, 2001
Influence of caveolin-1 on cellular cholesterol efflux mediated by high-density lipoproteinsP G Frank, F Galbiati, D Volonte, et al.
FEBS Letters|September 17, 1998
Mutational analysis of caveolin-induced vesicle formation. Expression of caveolin-1 recruits caveolin-2 to caveolae membranesS Li, F Galbiati, D Volonte, et al.
Pageof 3